These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16278330)

  • 1. I.V. admixture contamination rates: traditional practice site versus a class 1000 cleanroom.
    Thomas M; Sanborn MD; Couldry R
    Am J Health Syst Pharm; 2005 Nov; 62(22):2386-92. PubMed ID: 16278330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Method for testing aseptic technique of intravenous admixture personnel.
    Dirks I; Smith FM; Furtado D; White SJ; Godwin HN
    Am J Hosp Pharm; 1982 Mar; 39(3):457-9. PubMed ID: 7041641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved aseptic technique can reduce variable contamination rates of ward-prepared parenteral doses.
    Austin P; Elia M
    J Hosp Infect; 2013 Feb; 83(2):160-3. PubMed ID: 23313030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality.
    Stucki C; Sautter AM; Favet J; Bonnabry P
    Am J Health Syst Pharm; 2009 Nov; 66(22):2032-6. PubMed ID: 19890087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aseptic simulation test challenged with microorganisms for validation of pharmacy operators.
    Sigward E; Fourgeaud M; Vazquez R; Guerrault-Moro MN; Brossard D; Crauste-Manciet S
    Am J Health Syst Pharm; 2012 Jul; 69(14):1218-24. PubMed ID: 22761076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes.
    Krämer I; Federici M; Kaiser V; Thiesen J
    J Oncol Pharm Pract; 2016 Apr; 22(2):195-204. PubMed ID: 25549919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.
    Akers MJ
    Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating aseptic technique of pharmacy personnel.
    Brier KL
    Am J Hosp Pharm; 1983 Mar; 40(3):400-3. PubMed ID: 6342376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenterals laboratory course to reduce microbial contamination rates in media fill tests performed by pharmacy students.
    Isanhart CM; McCall KL; Kretschmer D; Grimes BA
    Am J Pharm Educ; 2008 Apr; 72(2):27. PubMed ID: 18483595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of compounding accuracy and aseptic techniques for intravenous admixtures.
    Sanders LH; Mabadeje SA; Avis KE; Cruze CA; Martinez DR
    Am J Hosp Pharm; 1978 May; 35(5):531-6. PubMed ID: 350042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding.
    Trissel LA; Gentempo JA; Anderson RW; Lajeunesse JD
    Am J Health Syst Pharm; 2005 Feb; 62(3):285-8. PubMed ID: 15719586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qaulity-control plan for intravenous admixture programs. II: Validation of operator technique.
    Morris BG; Avis KE; Bowles GC
    Am J Hosp Pharm; 1980 May; 37(5):668-72. PubMed ID: 7386475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation and microbiological stability of dose-banded ganciclovir infusion bags prepared in series by a robotic system.
    Krämer I; Federici M
    Eur J Hosp Pharm; 2020 Jul; 27(4):209-215. PubMed ID: 32587079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs.
    Geersing TH; Franssen EJF; Pilesi F; Crul M
    Eur J Pharm Sci; 2019 Mar; 130():181-185. PubMed ID: 30710619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for microbial contamination of ADD-Vantage admixtures.
    Hudson TJ; Ambroziak EM; Coley RM
    J Pharm Technol; 1992; 8(5):195-7. PubMed ID: 10121013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of the aseptic processing environment.
    Frieben WR
    Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.